Hepatitis E Diagnostic Tests Market: By Test Type, By Product Type By Distribution Channel, and Region Forecast 2019-2030   

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Hepatitis E Diagnostic Tests Market Size, Share, Growth, Trends, and Global Industry Analysis: By Test Type (RT-PCR Test, ELISA HEV IgM Test, and ELISA HEV IgG Test), By Product Type (Kits & Reagents) By Distribution Channel (Diagnostic Laboratories, Hospitals, and Others), and Region Forecast 2019-2030   

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Hepatitis E Diagnostic Tests Market size was valued at US$ 65.23 million in 2023 and is poised to grow at a significant CAGR of 4.5% from 2024-2030. Hepatitis E is caused by hepatitis E virus (HEV). The virus is a single-stranded ribonucleic acid (RNA) genome. The virus has four genotypes. Genotypes 1 and 2 have been found only in humans. Genotype 3 and 4 viruses circulate in several animals without causing any disease and is rarely infect humans. Definitive diagnosis of hepatitis E infection is usually based on the detection of specific IgM antibodies to the virus in a persons blood. The diagnosis of the hepatitis E is usually done by blood test or the stool test. Additional tests include reverse transcriptase polymerase chain reaction (RT-PCR) to detect the hepatitis E virus RNA in blood and/or stool.

summary download arrow Download Free Sample

Hepatitis E Diagnostic Tests Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.5%

Largest Market

Europe

Fastest Growing Market

North-America

Hepatitis E Diagnostic Tests Market Dynamics

Increase in the prevalence of hepatitis E is the key factor attributing the growth of the Hepatitis E diagnostic tests market. According to the World Health Organization (WHO), approximately 20 million people suffer from Hepatitis E each year, out of which 3.3 million are symptomatic cases and 56 600 hepatitis E-related deaths. The diagnosis of this virus is usually done using various testing kits such as ELISA HEV IgM test kits, ELISA HEV IgG test kits, RT-PCR test kits, and the prevalence of the disease is expected to provide opportunity to the manufacturers. However, the limited awareness among the people regarding the disease is hampering the growth of market. The high cost of the testing kits are likely to hider the growth of the Hepatitis E Diagnosis Market.

Hepatitis E Diagnostic Tests Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 65.23 million

Market CAGR

4.5%

By Test

  • RT-PCR Test
  • ELISA HEV IgM Test
  • ELISA HEV IgG Test

By Product

  • Kits
  • Reagents

By End User

  • Diagnostic Laboratories
  • Hospitals
  • Others

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

 

Key Features of the Report

  • The hepatitis e diagnostic tests market provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global hepatitis e diagnostic tests market size was valued at US$ 65.23 million in 2023 and is projected to grow at a CAGR of 4.5% from 2024 to 2030

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

Fast-track diagnostics Ltd, Altana Diagnostics GmbH, Beijing Wantai Biological Pharmacy, Mikrogen GmBH, Hoffmann-La Roche Ltd, Biokit S.A, MP Biomedicals LLC, Fortress Diagnostics Ltd.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Hepatitis E Diagnostic Tests Market Introduction 
2.1.Global Hepatitis E Diagnostic Tests Market  - Taxonomy
2.2.Global Hepatitis E Diagnostic Tests Market  - Definitions
2.2.1.Test
2.2.2.Product
2.2.3.End User
2.2.4.Region
3.Global Hepatitis E Diagnostic Tests Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Hepatitis E Diagnostic Tests Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Hepatitis E Diagnostic Tests Market  By Test, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. RT-PCR Test
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. ELISA HEV IgM Test
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. ELISA HEV IgG Test
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Hepatitis E Diagnostic Tests Market  By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Kits
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Reagents
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Hepatitis E Diagnostic Tests Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Diagnostic Laboratories
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Hospitals
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Hepatitis E Diagnostic Tests Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Hepatitis E Diagnostic Tests Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Test Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.RT-PCR Test
9.1.2.ELISA HEV IgM Test
9.1.3.ELISA HEV IgG Test
9.2.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Kits
9.2.2.Reagents
9.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Diagnostic Laboratories
9.3.2.Hospitals
9.3.3.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Hepatitis E Diagnostic Tests Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Test Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.RT-PCR Test
10.1.2.ELISA HEV IgM Test
10.1.3.ELISA HEV IgG Test
10.2.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Kits
10.2.2.Reagents
10.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Diagnostic Laboratories
10.3.2.Hospitals
10.3.3.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Hepatitis E Diagnostic Tests Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Test Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.RT-PCR Test
11.1.2.ELISA HEV IgM Test
11.1.3.ELISA HEV IgG Test
11.2.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Kits
11.2.2.Reagents
11.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Diagnostic Laboratories
11.3.2.Hospitals
11.3.3.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Hepatitis E Diagnostic Tests Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Test Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.RT-PCR Test
12.1.2.ELISA HEV IgM Test
12.1.3.ELISA HEV IgG Test
12.2.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Kits
12.2.2.Reagents
12.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Diagnostic Laboratories
12.3.2.Hospitals
12.3.3.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Hepatitis E Diagnostic Tests Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Test Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.RT-PCR Test
13.1.2.ELISA HEV IgM Test
13.1.3.ELISA HEV IgG Test
13.2.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Kits
13.2.2.Reagents
13.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Diagnostic Laboratories
13.3.2.Hospitals
13.3.3.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Fast-track diagnostics Ltd
14.2.2.Altana Diagnostics GmbH
14.2.3.Beijing Wantai Biological Pharmacy
14.2.4.Mikrogen GmBH
14.2.5.Hoffmann-La Roche Ltd
14.2.6.Biokit S.A
14.2.7.MP Biomedicals LLC
14.2.8.Fortress Diagnostics Ltd.
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Fast-track diagnostics Ltd
  • Altana Diagnostics GmbH
  • Beijing Wantai Biological Pharmacy
  • Mikrogen GmBH
  • Hoffmann-La Roche Ltd
  • Biokit S.A
  • MP Biomedicals LLC
  • Fortress Diagnostics Ltd.

Related Industry Reports

Global Ovarian Cancer Diagnostics Market

Global Infectious Disease Point Of Care Diagnostics Market

Global Infectious Disease Diagnostics Market

Global Cytomegalovirus Diagnostics Market